Cargando…

Survival benefits and challenges of adjuvant chemotherapy for high-grade osteosarcoma: a population-based study

BACKGROUND: Osteosarcoma is the most prevalent primary malignant bone tumor. The primary treatment for osteosarcoma is a combination of chemotherapy and surgery. However, there has been no recent progress in the role of chemotherapy in improving the long-term survival of osteosarcoma patients. This...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jinkui, Li, Mujie, Guo, Peng, He, Dawei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304229/ https://www.ncbi.nlm.nih.gov/pubmed/37370182 http://dx.doi.org/10.1186/s13018-023-03922-2

Ejemplares similares

Correction: Survival benefits and challenges of adjuvant chemotherapy for high-grade osteosarcoma: a population-based study
por: Wang, Jinkui, et al.
Publicado: (2023)

A Nomogram for Predicting Cancer-Specific Survival of Osteosarcoma and Ewing's Sarcoma in Children: A SEER Database Analysis
por: Wang, Jinkui, et al.
Publicado: (2022)

Exosome mimetics derived from bone marrow mesenchymal stem cells deliver doxorubicin to osteosarcoma in vitro and in vivo
por: Wang, Jinkui, et al.
Publicado: (2022)

A Web-Based Prediction Model for Cancer-Specific Survival of Elderly Patients With Clear Cell Renal Cell Carcinoma: A Population-Based Study
por: Zhanghuang, Chenghao, et al.
Publicado: (2022)

Development and Validation of Nomograms to Predict Cancer-Specific Survival and Overall Survival in Elderly Patients With Prostate Cancer: A Population-Based Study
por: Zhang, Zhaoxia, et al.
Publicado: (2022)

Amputation Predisposes to Higher Cancer-Specific Mortality Than Limb Salvage Surgery in Pediatric Patients With Osteosarcoma of the Limbs: A Propensity Matching Analysis
por: Wang, Jinkui, et al.
Publicado: (2022)

Survival Benefit of Adjuvant Chemotherapy in Pulmonary Carcinoid Tumors
por: Sobash, Philip T., et al.
Publicado: (2022)

A Nomogram for Predicting Cancer-Specific Survival in Children With Wilms Tumor: A Study Based on SEER Database and External Validation in China
por: Tan, Xiaojun, et al.
Publicado: (2022)

Development and validation of a nomogram to predict cancer-specific survival in elderly patients with papillary thyroid carcinoma: a population-based study
por: Wang, Jinkui, et al.
Publicado: (2022)

A Novel Tool to Predict the Overall Survival of High-Grade Osteosarcoma Patients after Neoadjuvant Chemotherapy: A Large Population-Based Cohort Study
por: Huang, Zhangheng, et al.
Publicado: (2022)

Development and Validation of a Competitive Risk Model in Elderly Patients With Chromophobe Cell Renal Carcinoma: A Population-Based Study
por: Wang, Jinkui, et al.
Publicado: (2022)

Significant survival benefit of adjuvant chemotherapy after concurrent chemoradiotherapy in locally advanced high-risk nasopharyngeal carcinoma
por: Liang, Zhong-Guo, et al.
Publicado: (2017)

Adjuvant Chemotherapy Associated with Survival Benefit Following Neoadjuvant Chemotherapy and Pancreatectomy for Pancreatic Ductal Adenocarcinoma: A Population-Based Cohort Study
por: Kamarajah, Sivesh K., et al.
Publicado: (2021)

The Role of Chemotherapy in the Survival Benefits of Patients Aged Older Than 40 Years With Osteosarcoma
por: Cao, Zhiyou, et al.
Publicado: (2021)

S-phase fraction and survival benefit from adjuvant chemotherapy or radiotherapy of breast cancer.
por: Stål, O., et al.
Publicado: (1994)

Preoperative Splenic Density for the Prediction of Survival and Adjuvant Chemotherapy Benefits in Gastric Cancer
por: Zhang, Wei-teng, et al.
Publicado: (2020)

Prognostic Factor and Survival Benefit of Adjuvant Chemotherapy in Stage IIA Colon Cancer
por: Lee, Mok-Won, et al.
Publicado: (2021)

Leptomeningeal spread in high-grade gliomas: Is surgery or adjuvant therapy after leptomeningeal spread associated with survival benefit?
por: Zhong, Shuai, et al.
Publicado: (2023)

High-grade focal areas in low-grade central osteosarcoma: high-grade or still low-grade osteosarcoma?
por: Righi, Alberto, et al.
Publicado: (2015)

Survival Prediction in High-grade Osteosarcoma Using Radiomics of Diagnostic Computed Tomography
por: Wu, Yan, et al.
Publicado: (2018)

A Delta-radiomics model for preoperative evaluation of Neoadjuvant chemotherapy response in high-grade osteosarcoma
por: Lin, Peng, et al.
Publicado: (2020)

Overall Survival Benefit in Rectal Cancer After Neoadjuvant Radiotherapy and Adjuvant Chemotherapy: A Propensity-Matched Population-Based Study
por: Chen, Zhiju, et al.
Publicado: (2020)

Survival benefit of adjuvant chemotherapy for patients with poorly differentiated stage IIA colon cancer
por: Liu, Qi, et al.
Publicado: (2019)

Prognostic Model That Predicts Benefits of Adjuvant Radiotherapy in Patients With High Grade Meningioma
por: Wang, Daijun, et al.
Publicado: (2020)

Candidate germline polymorphisms of genes belonging to the pathways of four drugs used in osteosarcoma standard chemotherapy associated with risk, survival and toxicity in non-metastatic high-grade osteosarcoma
por: Hattinger, Claudia M., et al.
Publicado: (2016)

The Uncertain Benefit of Adjuvant Chemotherapy in Advanced Low-Grade Serous Ovarian Cancer and the Pivotal Role of Surgical Cytoreduction
por: Johnson, Racheal Louise, et al.
Publicado: (2021)

Bone mineral density change during adjuvant chemotherapy in pediatric osteosarcoma
por: Ahn, Ju Hyun, et al.
Publicado: (2015)

The Effect of Adjuvant Chemotherapy on Localized Extraskeletal Osteosarcoma: A Systematic Review
por: Tsukamoto, Shinji, et al.
Publicado: (2022)

Adjuvant chemotherapy does not provide survival benefits to elderly patients with stage II colon cancer
por: Lee, Kil-yong, et al.
Publicado: (2019)

No survival benefit from adding chemotherapy to adjuvant radiation in advanced major salivary gland cancer
por: Kang, Nai-Wen, et al.
Publicado: (2022)

Dynamic recurrence risk and adjuvant chemotherapy benefit prediction by ctDNA in resected NSCLC
por: Qiu, Bin, et al.
Publicado: (2021)

A clinical prognostic scoring system for resectable gastric cancer to predict survival and benefit from paclitaxel- or oxaliplatin-based adjuvant chemotherapy
por: Qian, Jing, et al.
Publicado: (2016)

Comparative Survival Benefits of Surgery and Adjuvant Chemotherapy in Neuroendocrine Carcinoma of the Gallbladder: A Population-Based Study with Insight into Future Personalized Therapeutic Approach
por: Khan, Jaffar, et al.
Publicado: (2023)

Survival benefit and impact of adjuvant chemotherapy following systemic neoadjuvant chemotherapy in patients with resected pancreas ductal adenocarcinoma: a retrospective cohort study
por: Pu, Ning, et al.
Publicado: (2023)

Giant abdominal osteosarcoma causing intestinal obstruction treated with resection and adjuvant chemotherapy
por: Diamantis, Alexandros, et al.
Publicado: (2017)

Long-term adjuvant metronomic chemotherapy in a dog with recurrent maxillofacial osteosarcoma
por: Jung, Min-Jung, et al.
Publicado: (2023)

Perioperative chemotherapy more of a benefit for overall survival than adjuvant chemotherapy for operable gastric cancer: an updated Meta-analysis
por: Yang, Ya’nan, et al.
Publicado: (2015)

Randomised trial: survival benefit and safety of adjuvant dose-dense chemotherapy for node-positive breast cancer
por: Kümmel, S, et al.
Publicado: (2006)

Genomic signatures for predicting survival and adjuvant chemotherapy benefit in patients with non-small-cell lung cancer
por: Van Laar, Ryan K
Publicado: (2012)

Is there an optimal time to initiate adjuvant chemotherapy to predict benefit of survival in non-small cell lung cancer?
por: Liu, Yutao, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_umno0j5nnvn29bqab3h4ht64i1